Why Oppenheimer Is Downgrading Qualcomm Now

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Why Oppenheimer Is Downgrading Qualcomm Now

© Thinkstock

Qualcomm Inc. (NASDAQ: QCOM) has seen its shares struggle over the past two years, down by over a third from its mid-2014 highs. One key analyst is acknowledging that sentiment is likely very low. The stock appears cheap, and Qualcomm boasts a strong balance sheet and solid capital return. However this key analyst sees continued structural challenges to the company’s core business, and as a result the stock was downgraded.

Oppenheimer downgraded of Qualcomm to a Perform rating from Outperform and removed the $67 price target. Earnings estimates were reduced as well. A lack of tangible catalysts is likely to keep a lid on shares for the foreseeable future. With risk/reward in balance, Oppenheimer is stepping to the sidelines here.

The company’s core mobile business expects to continue to face pressure from flattening smartphone growth, vertical integration at key customers and stiff competition.

The brokerage firm detailed in its report:

Qualcomm is over-exposed to mobile, in our view. This segment offers diminishing growth, poor visibility and increasing competition. We see M&A as QCOM’s best option to diversify into stickier, higher profit markets. Qualcomm has ~$31 billion cash and generates free cash flow of ~$6 billion/yr. While M&A strategy has focused on tuck-ins, we believe the opportunity exists to take a more aggressive stance toward “gamechanging” M&A.

Oppenheimer also reduced its estimates for the next two calendar years. For 2016, the firm dropped its earnings per share (EPS) estimates to $4.00 on $22.5 billion in revenue from $4.05 per share on $21.93 billion. For 2017, estimates were reduced to $4.35 in EPS on $23.2 billion in revenue from $4.46 and $22.95 billion.

Shares of Qualcomm were trading at $52.25 on Friday, with a consensus analyst price target of $57.55 and a 52-week trading range of $42.24 to $74.09.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618